-
Don’t Miss: Sorrento Therapeutics (NASDAQ:SRNE), Marinus Pharmaceuticals (NASDAQ:MRNS), Northern Dynasty Minerals (NYSEMKT:NAK), Vital Therapies (NASDAQ:VTL), Parkervision Inc. (NASDAQ:PRKR)
On Wednesday shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) closed at $10.97. On May 04, Sorrento Therapeutics, Inc. (NASDAQ:SRNE) announce positive results from recently analyzed pharmacokinetic (PK) data from its TRIBECA (TRIal establishing BioEquivalence between Cynviloq™ and Albumin-bound paclitaxel) registrational trial. Data analysis suggests that Cynviloq meets the bioequivalence (BE) criteria for both total and unbound…
-
Morning Watch List: Build-A-Bear Workshop Inc. (NYSE:BBW), Marinus Pharmaceuticals (NASDAQ:MRNS), Baidu Inc (NASDAQ:BIDU), Allied World Assurance Company (NYSE:AWH), INSYS Therapeutics (NASDAQ:INSY)
On Tuesday shares of Build-A-Bear Workshop Inc. (NYSE:BBW) closed at $20.55. Company’s sales growth for last 5 years was -0.20% and EPS growth for next 5 years is recorded as 30.00%. Build-A-Bear Workshop, Inc. (NYSE:BBW), an interactive entertainment retailer of customized stuffed animals, announced the appointment of Chris Hurt to the position of chief operations…
-
Active Stocks to Watch: Relypsa (NASDAQ:RLYP), Micron Technology (NASDAQ:MU), QUALCOMM (NASDAQ:QCOM), Marinus Pharmaceuticals (NASDAQ:MRNS), Emergent BioSolutions (NYSE:EBS)
On Wednesday shares of Relypsa, Inc. (NASDAQ:RLYP) closed at $33.92. On Mar 16, Relypsa, Inc. (NASDAQ:RLYP) highlighted multiple data presentations of Patiromer for Oral Suspension (FOS) at the 2015 World Congress of Nephrology. Patiromer FOS, Relypsa’s lead product candidate, is an oral potassium binder being developed for the treatment of hyperkalemia. Micron Technology, Inc. (NASDAQ:MU)…
-
Stocks to Watch: LinkedIn Corporation (NYSE:LNKD), Marinus Pharmaceuticals (NASDAQ:MRNS), Renasant Corp. (NASDAQ:RNST), Hallador Energy Company (NASDAQ:HNRG), AMC Networks Inc. (NASDAQ:AMCX)
On Tuesday shares of LinkedIn Corporation (NYSE:LNKD) closed at $264.16. Company’s sales growth for last 5 years was 79.20% and EPS growth for next 5 years is recorded as 40.61%. After nearly a year-long gap of going live on iOS, LinkedIn Corp (NYSE:LNKD) has rolled out its job search app for Android. The company said…
-
Biotech Top Losers: Acorda Therapeutics (NASDAQ:ACOR), Actinium Pharmaceuticals (NYSEMKT:ATNM), Onconova Therapeutics (NASDAQ:ONTX), Marinus Pharmaceuticals (NASDAQ:MRNS), Bio Blast Pharma (NASDAQ:ORPN)
Acorda Therapeutics Inc. (NASDAQ:ACOR) announced that it will host a conference call and live webcast to report its fourth quarter and year end 2014 financial results on Thursday February 12 at 8:30 a.m. ET. On Tuesday shares of Acorda Therapeutics, Inc. (NASDAQ:ACOR) closed at $36.06. Company’s sales growth for last 5 years was 47.70% and…
-
Sizzling Stocks: Marinus Pharmaceuticals (NASDAQ:MRNS), Office Depot (NASDAQ:ODP), National Retail Properties (NYSE:NNN), Hanwha Solarone Co Ltd (NASDAQ:HSOL), FireEye (NASDAQ:FEYE)
On 3 February, Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), announced that it has initiated a Phase 2 clinical trial with ganaxolone, a synthetic analog of the endogenous neurosteroid allopregnanolone, in female children with epilepsy caused by a mutation of the protocadherin 19 gene (PCDH19). On Friday shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) closed at $10.98. Juan E.…
-
Traders Buzz: AK Steel Holding Corporation (NYSE:AKS), Marinus Pharmaceuticals (NASDAQ:MRNS), Triangle Capital Corporation (NYSE:TCAP), UTStarcom Holdings Corp. (NASDAQ:UTSI), Weyerhaeuser Co. (NYSE:WY)
On 27 January, AK Steel Holding Corporation (NYSE:AKS) reported a better-than-expected quarterly profit, helped by strong demand from automakers. U.S. auto sales rose 4.6 percent to 10.8 percent in the fourth quarter. On Thursday shares of AK Steel Holding Corporation (NYSE:AKS) closed at $4.11. Company’s sales growth for last 5 years was 9.80% and EPS…
-
Stocks News Alert: Twenty-First Century Fox (NASDAQ:FOXA), Marinus Pharmaceuticals (NASDAQ:MRNS), Canadian Imperial Bank of Commerce (NYSE:CM), SLAB, Panhandle Oil and Gas (NYSE:PHX)
Twenty-First Century Fox Inc (NASDAQ:FOXA) will be releasing its financial results on Wednesday after the market closes. The company would likely to report not only a year-over-year fall in revenue but also sequentially. On Tuesday shares of Twenty-First Century Fox, Inc. (NASDAQ:FOXA) closed at $34.60. Company’s sales growth for last 5 years was 0.90% and…
-
Big Moves in Focus: Idera Pharmaceuticals (NASDAQ:IDRA), Marinus Pharmaceuticals (NASDAQ:MRNS), Oracle Corporation (NYSE:ORCL), Amdocs Limited (NASDAQ:DOX), SINA Corporation (NASDAQ:SINA)
Idera Pharmaceuticals, Inc. (Nasdaq:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and rare diseases, announced that Vincent Milano, Idera’s Chief Executive Officer will present a corporate update at the 33rd Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2015 at 10:30 a.m. Pacific Time / 1:30 p.m.…
-
Why Investors Are Watching: Marinus Pharmaceuticals (NASDAQ:MRNS), Eagle Pharmaceuticals Inc. (NASDAQ:EGRX), Universal Health Services (NYSE:UHS), First Mid-Illinois Bancshares (NASDAQ:FMBH), Ericsson (NASDAQ:ERIC)
On December 3, 2014, Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) entered into a First Amendment to Loan and Security Agreement (the “Loan Agreement”) with Square 1 Bank (the “Amendment”). The Amendment increases the term loan availability under the Loan Agreement from $2.0 million to $12.0 million. In addition to the $2.0 million term loan currently outstanding, borrowed…